| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.13 | 0.3 |